Chiron Capital Management, LLC 23and Me Holding Co. Transaction History

Chiron Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$1.59 - $2.29 $6,201 - $8,931	-3,900 Reduced 18.93%	16,700 $29,000
Q1 2023 Apr 21, 2023	SELL	$2.05 - $2.87 $6,559 - $9,184	-3,200 Reduced 13.45%	20,600 $46,000
Q4 2022 Jan 23, 2023	SELL	$2.06 - $3.47 $3,914 - $6,593	-1,900 Reduced 7.39%	23,800 $0
Q3 2022 Oct 13, 2022	BUY	$2.6 - $5.12 $14,560 - $28,672	5,600 Added 27.86%	25,700 $74,000
Q2 2022 Jul 25, 2022	BUY	$2.19 - $3.98 $44,019 - $79,998	20,100 New	20,100 $50,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Chiron Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chiron Capital Management, LLC with notifications on news.